Xu-Huhmann Annie

Cadre supérieur

Insider activity · 24 months2 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 2 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 1 saleJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (2 ops.)

—

▼ Sales (1 ops.)

€86k

Latest filing published 11 Jun 2026 for BEKAERT, €86k. Read the official filing

Filing timeline

BuySale

Xu-Huhmann Annie

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Closed purchases

Market purchases

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

BEKAERT 2 purchases · last 20 Mar 2026

Xu-Huhmann Annie: trading record in brief

This profile gathers the share dealings of Xu-Huhmann Annie in Bekaert, where the filings describe the role as senior executive. Over a trading history stretching from 16 March 2026 to 8 June 2026, the count stands at 3 filings.

The open-market side counts 2 purchases alongside 1 sale for €86k. The amount is not disclosed for 2 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

On 11 June 2026 came the latest disclosure, an open-market sale for €86k in Bekaert. The most recent open-market purchase was published on 20 March 2026, 212 days ago. Between a trade and the moment it shows up on FSMA, the median delay is 4 days. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by FSMA. They describe what insiders did and are not a recommendation.